Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 108Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Harnal

02 3Harnal/Omnic

03 1Omnic

PharmaCompass

01

Brand Name : Harnal/Omnic

Tamsulosin

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Harnal/Omnic

arrow
Medlab Asia & Asia Health
Not Confirmed

Tamsulosin

Main Therapeutic Indication : Nephrology

Currency : USD

2020 Revenue in Millions : 351

2019 Revenue in Millions : 411

Growth (%) : -15

blank

02

Brand Name : Harnal/Omnic

Tamsulosin

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Harnal/Omnic

arrow
Medlab Asia & Asia Health
Not Confirmed

Tamsulosin

Main Therapeutic Indication : Nephrology

Currency : USD

2021 Revenue in Millions : 226

2020 Revenue in Millions : 349

Growth (%) : -30

blank

03

Brand Name : Omnic

Tamsulosin

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Omnic

arrow
Medlab Asia & Asia Health
Not Confirmed

Tamsulosin

Main Therapeutic Indication : Nephrology

Currency : USD

2022 Revenue in Millions : 69

2021 Revenue in Millions : 72

Growth (%) : -4

blank

04

Brand Name : Harnal

Tamsulosin

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Harnal

arrow
Medlab Asia & Asia Health
Not Confirmed

Tamsulosin

Main Therapeutic Indication : Nephrology

Currency : USD

2022 Revenue in Millions : 215

2021 Revenue in Millions : 227

Growth (%) : -5

blank

05

Brand Name : Harnal/Omnic

Tamsulosin

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Harnal/Omnic

arrow
Medlab Asia & Asia Health
Not Confirmed

Tamsulosin

Main Therapeutic Indication : Nephrology

Currency : USD

2019 Revenue in Millions : 417

2018 Revenue in Millions : 441

Growth (%) : -5

blank